Digital Content 
NEWS #PharmaBuzz
19 Oct 2025
// PR NEWSWIRE
https://www.prnewswire.com/news-releases/significant-os-benefit-with-cadonilimab-in-first-line-advanced-gastric-cancer-final-analysis-of-compassion-15-presented-at-esmo-2025-302588409.html
17 Oct 2025
// BUSINESSWIRE
https://www.businesswire.com/news/home/20251017239598/en/IMFINZI-durvalumab-based-regimen-reduced-the-risk-of-death-by-22-in-early-gastric-cancer-vs.-chemotherapy-alone-in-MATTERHORN-Phase-III-trial
18 Sep 2025
// PR NEWSWIRE
https://www.prnewswire.com/news-releases/korea-university-study-identifies-age-70-as-cutoff-for-chemotherapy-benefit-in-colorectal-cancer-302560004.html
19 Jul 2025
// PRESS RELEASE
https://www.gene.com/media/press-releases/15070/2025-07-18/genentech-provides-update-on-supplementa
31 May 2025
// GLOBENEWSWIRE
https://www.globenewswire.com/news-release/2025/05/31/3091404/0/en/Late-breaking-analysis-demonstrates-characteristics-associated-with-long-term-overall-survival-with-Onivyde-regimen-in-metastatic-pancreatic-adenocarcinoma.html
30 May 2025
// BUSINESSWIRE
https://www.businesswire.com/news/home/20250530872619/en/Pfizers-BRAFTOVI-Combination-Regimen-Cuts-the-Risk-of-Death-in-Half-for-Patients-with-BRAF-V600E-Mutant-Metastatic-Colorectal-Cancer
Share 